iNATT logo

Clinical Trial Now Open in UK

An open label, single arm, multi-centre, phase 2 trial of lenvatinib for the treatment of anaplastic thyroid cancer (ATC)


3 UK centres are being opened:

The Royal Marsden Hospital: London (Dr Kate Newbold)

Velindre Cancer Centre: Cardiff (Dr Laura Moss)

Beatson West of Scotland Cancer Centre: Glasgow (Prof Nick Reed)


Dr. Laura Moss
Velindre Hospital, Velindre Road, Whitchurch, Cardiff, CF14 2TL